Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Ended earlyNCT00004239What this trial is testing506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver ImpairmentWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more Alliance for Clinical Trials in Oncology 10
Early research (Phase 1)Study completedNCT00028496What this trial is testingVaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more National Cancer Institute (NCI) 48
Early research (Phase 1)Study completedNCT01421524What this trial is testingStudy of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple MyelomaWho this might be right forMultiple MyelomaLymphoma, Large B-Cell, DiffusePleiotropic Pathway Modifier+3 more Celgene 271
Early research (Phase 1)Study completedNCT00118170What this trial is testingSorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney FunctionWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Burkitt Lymphoma+42 more National Cancer Institute (NCI) 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT06521567What this trial is testingCobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With CancerWho this might be right forMelanomaHodgkin LymphomaHigh and Low Grade Glioma+9 more GlaxoSmithKline 83
Early research (Phase 1)Study completedNCT00608361What this trial is testingDasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By SurgeryWho this might be right forAdult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic LeukemiaAdult Hepatocellular Carcinoma+82 more National Cancer Institute (NCI) 80
Not applicableStudy completedNCT03601845What this trial is testingMRE-IA in Liver Disease and Neurovascular ImagingWho this might be right forDiffuse and Focal Liver Diseases, Cerebral Function Université de Sherbrooke 59
Not applicableEnrolling By InvitationNCT02422875What this trial is testingComparative Autoantibody and Immunologic Cell Marker StudyWho this might be right forAutoimmune DiseasesLupus Erythematosus, SystemicCommunicable Diseases Emory University 2,500
Not applicableEnded earlyNCT02086708What this trial is testingUltrasound Method to Measure Fibrosis of the Liver in ChildrenWho this might be right forChronic Liver DiseaseNon-Alcoholic Fatty Liver DiseaseHCV Coinfection+2 more Massachusetts General Hospital 24
Early research (Phase 1)Study completedNCT00499811What this trial is testingVorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver DysfunctionWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+60 more National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT00004178What this trial is testingGene Therapy in Treating Patients With CancerWho this might be right forCancer Roger Williams Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT06389422What this trial is testingPhase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor ThrombosisWho this might be right forHepatocellular CarcinomaRadiotherapyPembrolizumab+1 more Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Early research (Phase 1)Study completedNCT00073944What this trial is testingBCX-1777 in Treating Patients With Refractory CancerWho this might be right forCancer BioCryst Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT00788125What this trial is testingDasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more City of Hope Medical Center 7
Testing effectiveness (Phase 2)Ended earlyNCT00588146What this trial is testingPhase 2 Study of PEG-Intron in Hereditary Hemorrhagic TelangiectasiaWho this might be right forAnemiaLiver DiseaseHypoxemia Mayo Clinic 10
Early research (Phase 1)Study completedNCT00019513What this trial is testingCombination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasWho this might be right forColorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more National Institutes of Health Clinical Center (CC) 108
Early research (Phase 1)Study completedNCT03329950What this trial is testingCDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesWho this might be right forMelanomaNon-small Cell Lung CancerBreast Cancer+23 more Celldex Therapeutics 132
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Not applicableUnknownNCT04626492What this trial is testingQuantitative MRI Imaging in Diffuse Liver DiseasesWho this might be right forFibrosis and Cirrhosis of Liver Fifth Affiliated Hospital, Sun Yat-Sen University 150